Olanzapine Long-Acting Injection: A 24-Week, Randomized, Double-Blind Trial of Maintenance Treatment in Patients With Schizophrenia
Authors:
- John M. KaneJKJohn M. Kane
- Holland C. DetkeHDHolland C. Detke
- Dieter NaberDNDieter Naber
- Gopalan SethuramanGSGopalan Sethuraman
- Daniel Y. LinDLDaniel Y. Lin
- Richard F. BergstromRBRichard F. Bergstrom
- David McDonnellDMDavid McDonnell
- 1 February 2010
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 167 (2) , 181-189
Abstract
ObjectiveThe purpose of the present study was to evaluate the efficacy and tolerability of olanzapine long-acting injection for maintenance treatment of schizophrenia. MethodOutpatients with schizophrenia who had maintained stability on an oral regimen of olanzapine (10, 15, or 20 mg/day) for 4 to 8 weeks were randomly assigned to 24 weeks of double-blind treatment with "low" (150 mg every 2 weeks; N=140), "medium" (405 mg every 4 weeks; N=318), or "high" (300 mg every 2 weeks; N=141) doses of olanzapine long-acting injection; a very low reference dose of olanzapine long-acting injection (45 mg every 4 weeks; N=144); or their stabilized dose of oral olanzapine (N=322). Rates of and time to psychotic exacerbation were estimated using Kaplan-Meier methodology. ResultsAt 24 weeks, the majority of oral olanzapine-treated patients (93%), as well as most olanzapine long-acting injection-treated patients receiving high (95%), medium (90%), low (84%), and very low doses (69%), remained exacerbation free, with the...Keywords
This publication has 14 references indexed in Scilit:
- Standards of Medical Care in DiabetesDiabetes Care, 2004
- A Double-Blind, Randomized, Placebo-Controlled Trial of Olanzapine in the Prevention of Psychotic RelapseJournal of Clinical Psychopharmacology, 2003
- Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final ReportCirculation, 2002
- Predictors of Relapse Following Response From a First Episode of Schizophrenia or Schizoaffective DisorderArchives of General Psychiatry, 1999
- Standard olanzapine versus placebo and ineffective-dose olanzapine in the maintenance treatment of schizophreniaPsychiatric Services, 1997
- A Rating Scale for Drug-Induced AkathisiaThe British Journal of Psychiatry, 1989
- The Positive and Negative Syndrome Scale (PANSS) for SchizophreniaSchizophrenia Bulletin, 1987
- Fluphenazine and Social Therapy in the Aftercare of Schizophrenic PatientsArchives of General Psychiatry, 1979
- Systemic Toxic Reactions to Procaine Penicillin GSexually Transmitted Diseases, 1978
- A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTSActa Psychiatrica Scandinavica, 1970